SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,81,000 KRW | -0.76% |
|
+1.30% | +2.76% |
| 06/05 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
| 25/04 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.
- Total Return chart